ARCHIVES

What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review

This article is from The Cancer Letter archive.

Vol. 39 No. 46 | December 13, 2013

Download PDF Visit The Full Archive

Related Articles

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013